Professional Documents
Culture Documents
Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
CRITICAL APPRAISAL
Smoking Intensity, Oxidative Stress and
Chemotherapy in Non-Small Cell Lung Cancer:
EBM
Population
Intervention
: Merokok
Comparison
Outcomes
: www.web.ebscohost.com
Kata kunci
Limitasi
Hasil Pencarian
:7
REVIEW JURNAL
Pendahuluan
Previous studies indicated that lower smoking intensity is associated with favorable overall
survival of non small cell cancer. This is because smoking affects the rates of metabolism for
several drugs. It was also seen that lung function in smokers maybe more chemo resistant. The
resistant of cancer cells to anticancer drugs is a serious clinical problem encountered in
chemotherapy (CT) of lung cancer patients.
The end of the present work was to study the relationship of different smoking intensity with
oxidative stress and survival after platinum based chemotherapy in non small cell lung cancer
patients.
Metoda
A prospective cohort study with 2 years follow-up was carried out in India, including 203
patients with previously untreated, histologycally or cytologically confirmed. Patients were
classified into two catagories based on cigarrette status: non smoker and smokers the patients who
had stopped smoking recently were considered as current smokers. Patients who had quit smoking
for more than one year were considered former smokers. Smoking intensity of the smokers was
calculated as pack year (PY) smoked. Patients were stratified into three groups (1-20, 21-50, and
>50) by different smoking intensity cut off values in the analysis. Patients received chemotherapy
for a maximum of six cycles. Blood spesiment were analysed with bio chemical assay.
2
Hasil
The overall median survival of all NSCLC was found to be 28,50 weeks. The overall
median survival of smoker NSCLC patients was significantly lower as compared to non smoker
NSCLC patients. The death rate in smoker NSCLC patients were also 0,22 times higher than the
death rate of non smoker NSCLC patients.
Kesimpulan
Smoking is a bad prognostic factor in lung cancer therapy, besides it's role in oxidative
stress, lung cancer genesis and poor survival. Therefore, this factor can be used in patient selection
for chemo prevention.
APAKAH HASIL PENELITIAN TERSEBUT VALID?
A. Petunjuk Primer
1. Apakah terdapat sampel yang representatif, terdefinisi jelas, dan berada pada kondisi yang sama
dalam perjalanan penyakitnya?
B. Petunjuk sekunder
1. Apakah kriteria outcome yang digunakan obyektif dan tanpa bias?
2. Bila ditemukan subgrup dengan prognosis yang beda, apakah dilakukan adjustment untuk faktorfaktor prognostik yang penting?
APA HASILNYA?
1. Bagaimana gambaran outcome menurut waktu?